Skip to main content

Table 3 Association of GA/HbA1c ratio with all-cause mortality after exclusion of participants who died within first 2 years of follow-up

From: L-shaped association between the GA/HbA1c ratio and all-cause mortality in U.S. adults with NAFLD: a cross-sectional study from the NHANES 1999–2004

GA/HbA1c ratio

Total

Events

Model 1

Model 2

Model 3

HR (95%CI), P

HR (95%CI), P

HR (95%CI), P

All-cause mortality

 GA/HbA1c ratio (continuous)

5,188

1,364

1.27(1.05,1.53), 0.015

1.25(1.05,1.48), 0.010

1.22(1.03,1.44), 0.022

 GA/HbA1c (categorical)

   Tertile 1

1,654

353

1 [Reference]

1 [Reference]

1 [Reference]

   Tertile 2

1,797

427

1.14(0.95,1.36), 0.175

1.10(0.92,1.31), 0.315

1.15(0.96,1.38), 0.123

  Tertile 3

1,737

584

1.57(1.32,1.87), < 0.001

1.35(1.14,1.60), < 0.001

1.26(1.05,1.51), 0.012

P for trend

  

< 0.001

< 0.001

0.002

  1. Model 1: unadjusted
  2. Model 2: adjusted for age, sex and race
  3. Model 3: adjusted for model 2 plus education level, marital status, poverty income ratio, hypertension, diabetes, cardiovascular disease, cancer, smoker, physical activity, estimated glomerular filtration rate, body mass index and nafld fibrosis score
  4. Abbreviation: HR Hazard ratio, CI Confidence interval